<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">83602</article-id><article-id pub-id-type="doi">10.7554/eLife.83602</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Computational and Systems Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>Drug specificity and affinity are encoded in the probability of cryptic pocket opening in myosin motor domains</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-171495"><name><surname>Meller</surname><given-names>Artur</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5504-2684</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-295241"><name><surname>Lotthammer</surname><given-names>Jeffrey M.</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-295242"><name><surname>Smith</surname><given-names>Louis G</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-295315"><name><surname>Novak</surname><given-names>Borna</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-295316"><name><surname>Lee</surname><given-names>Lindsey A</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-295317"><name><surname>Kuhn</surname><given-names>Catherine C</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-132309"><name><surname>Greenberg</surname><given-names>Lina</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-75477"><name><surname>Leinwand</surname><given-names>Leslie A</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1470-4810</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-132306"><name><surname>Greenberg</surname><given-names>Michael J</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1320-3547</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-94093"><name><surname>Bowman</surname><given-names>Gregory R</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2083-4892</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Biochemistry and Molecular Biophysics</institution>, <institution>Washington University in St. Louis</institution>, <addr-line><named-content content-type="city">St Louis</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Biochemistry and Biophysics</institution>, <institution>University of Pennsylvania</institution>, <addr-line><named-content content-type="city">Philadelphia</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Department of Biochemistry and Molecular Biophysics</institution>, <institution>Washington University in St. Louis</institution>, <addr-line><named-content content-type="city">St. Louis</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Department of Molecular, Cellular, and Developmental Biology</institution>, <institution>University of Colorado Boulder</institution>, <addr-line><named-content content-type="city">Boulder</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-206904"><name><surname>Hamelberg</surname><given-names>Donald</given-names></name><role>Reviewing editor</role><aff><institution>Georgia State University</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>grbowman@seas.upenn.edu</email> (GB);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>27</day><month>01</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e83602</elocation-id><history><date date-type="received"><day>21</day><month>09</month><year>2022</year></date><date date-type="accepted"><day>23</day><month>01</month><year>2023</year></date></history><permissions><copyright-statement>© 2023, Meller et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Meller et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-83602-v1.pdf"/><abstract><p>The design of compounds that can discriminate between closely related target proteins remains a central challenge in drug discovery. Specific therapeutics targeting the highly conserved myosin motor family are urgently needed as mutations in at least 6 of its members cause numerous diseases. Allosteric modulators, like the myosin-II inhibitor blebbistatin, are a promising means to achieve specificity. However, it remains unclear why blebbistatin inhibits myosin-II motors with different potencies given that it binds at a highly conserved pocket that is always closed in blebbistatin-free experimental structures. We hypothesized that the probability of pocket opening is an important determinant of the potency of compounds like blebbistatin. To test this hypothesis, we used Markov state models (MSMs) built from over 2 milliseconds of aggregate molecular dynamics simulations with explicit solvent. We find that blebbistatin’s binding pocket readily opens in simulations of blebbistatin-sensitive myosin isoforms. Comparing these conformational ensembles reveals that the probability of pocket opening correctly identifies which isoforms are most sensitive to blebbistatin inhibition and that docking against MSMs quantitatively predicts blebbistatin binding affinities (R<sup>2</sup>=0.82). In a blind prediction for an isoform (Myh7b) whose blebbistatin sensitivity was unknown, we find good agreement between predicted and measured IC50s (0.67 mM vs. 0.36 mM). Therefore, we expect this framework to be useful for the development of novel specific drugs across numerous protein targets.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>1F30HL162431-01A1</award-id><principal-award-recipient><name><surname>Meller</surname><given-names>Artur</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01 GM124007</award-id><principal-award-recipient><name><surname>Bowman</surname><given-names>Gregory R</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>RF1AG067194</award-id><principal-award-recipient><name><surname>Bowman</surname><given-names>Gregory R</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01 HL141086</award-id><principal-award-recipient><name><surname>Greenberg</surname><given-names>Michael J</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>GM 20909</award-id><principal-award-recipient><name><surname>Leinwand</surname><given-names>Leslie A</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000001</institution-id><institution>National Science Foundation</institution></institution-wrap></funding-source><award-id>DGE2139839</award-id><principal-award-recipient><name><surname>Lotthammer</surname><given-names>Jeffrey M.</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000001</institution-id><institution>National Science Foundation</institution></institution-wrap></funding-source><award-id>MCB-1552471</award-id><principal-award-recipient><name><surname>Bowman</surname><given-names>Gregory R</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Experimental, pocket volume, docking, and trajectory clustering data have been deposited in OSF under accession code CV6D2. Scripts and notebooks used to generate all figures are available in our GitHub repository (https://github.com/bowman-lab/blebbistatin-specificity).</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Meller A</collab><collab>Lotthammer JM</collab><collab>Smith LG</collab><collab>Novak B</collab><collab>Lee LA</collab><collab>Kuhn CK</collab><collab>Greenberg L</collab><collab>Leinwand LA</collab><collab>Greenberg MJ</collab><collab>Bowman GR</collab></person-group><year iso-8601-date="2022">2022</year><source>class2-myosin-isoforms</source><ext-link ext-link-type="uri" xlink:href="https://osf.io/cv6d2/">https://osf.io/cv6d2/</ext-link><comment>OSF, CV6D2</comment></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset2" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Justin R Porter</collab><collab>Artur Meller</collab><collab>Maxwell I Zimmerman</collab><collab>Michael J Greenberg</collab><collab>Gregory R Bowman</collab></person-group><year iso-8601-date="2019">2019</year><source>myosin-isoforms</source><ext-link ext-link-type="uri" xlink:href="https://osf.io/54g7p/">https://osf.io/54g7p/</ext-link><comment>OSF, 10.17605/OSF.IO/54G7P</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-83602-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>